Amoébaamoeba-biocide.com. Amoeba provides industry with the most powerful disruptive biocide to eliminate bacteria - Legionella, amoeba and biofilm- in water.
|
Cytoocytoo.com. CYTOO is a biotechnology company specialized in the development of physiologically-relevant cellular models and assays for High Content Screening (HCS).
|
Domain Therapeuticsdomaintherapeutics.com. Domain Therapeutics is using transmembrane and G Protein-Coupled Receptor (GPCR) targeting for the discovery and development of innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer.
|
EnobraQenobraq.com. EnobraQ develops a baker's yeast that uses CO2 as carbon source and H2 as energy source.
|
|
Erytech Pharmaerytech.com. Erytech Pharma develops innovative cancer therapies ; its proprietary technology is based on encapsulation of therapeutic molecules into red blood cells.
|
Evolvaevolva.com. Evolva discovers and provides innovative high value, sustainable ingredients, with an emphasis on health, wellness and nutrition.
|
Exeliom Biosciencesexeliombio.com. Exeliom Biosciences develops a new class of microbiota-based innovative therapeutic products to treat inflammatory bowel diseases.
|
|
Fab'entechfabentech.com. Fab'entech is a company specialized in passive immunotherapy based on specific polyclonal immunoglobulins [F(ab')2] against emerging infectious diseases.
|
|
Firalisfiralis.com. Firalis is a biotechnology company with a mission to create novel values via biomarker discovery, development and regulatory qualification that ultimately lead to biomarker-based diagnostics.
|
Flash Therapeuticsflashtherapeutics.com. Flash Therapeutics is a gene therapy company developing new generation of non-integrative RNA carriers for therapeutic applications
|
Gamida Cellgamida-cell.com. Leader in immuno oncology, Gamida Cell develops treatments for orphan hematological diseases and malignancies using stem cells and NK cells.
|
|
Genoceagenocea.com. Genocea discovers and develops vaccines and immunotherapies using a transformational technology platform for T cell antigen discovery.
|
Hybrigenicshybrigenics.com. Bio-pharmaceutical company with a focus on research and development of new targets & therapies against proliferative diseases. Hybrigenic's current development program is based on inecalcitol, a vitamin D receptor agonist being studied in 3 potential applications (lymphocytic and myeloid leukaemia and prostate cancer) .
|
|
Icagenicagen.com. Icagen offers industry-leading scientific expertise and comprehensive services for ion channel and transporter drug discovery and development.
|
Innate Pharmainnate-pharma.com. Clinical-stage biotechnology company with a focus on discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
|
Isocellglisodine.fr. Isocell has developed a proprietary formulation for Super-Oxyde Dismutase (SOD); a powerful anti-oxydant for which formulation has always been the major stumbling block. Strong scientific evidence has shown the benefits of SOD namely (prevention of cardio-vascular diseases). The company is also targeting the functional food area (sodas, sports drinks, dairies ... with wellness claims).
|
|
NicOxnicox.com. Nicox is an international ophtalmic R&D company, aiming to build a diversified portofio of therapeutic products adressing the needs of eyecare practitioners and patients around the world.
|
|
Nosopharmnosopharm.com. Innovative anti-infective drug discovery targeting the bacterial multidrug resistance to antibiotics.
|
Novagali Pharmasanten.com. Innovative drug formulations to treat eye disorders.
|
|
Onxeoonxeo.com. Onxeo is a biopharmaceutical company specialist in the development of oncology products.
|
Pherecydes Pharmapherecydes-pharma.com. Pherecydes Pharma is an innovative company specialized in phage therapy developing phages to fight infections.
|
|
PopulationGeneticspopgentech.com. Population Genetics has developed a broad portfolio of patents covering revolutionary technologies that will have a major impact on the use of next generation sequencing (NGS) for a broad range of applications.
|
|
Pylotepylote.com. Pylote conceives and develops innovative mineral microspheres to sell solutions which can be integrated into numerous consumer products without any change to the existing manufacturing process.
|
Spine Nextabbott.com. Innovative Spine implants.
|
Targaceptcatalystbiosciences.com. Development of innovative neuronal nicotinic receptor-based therapies. Merged with Catalyst Biosciences.
|
Theranexustheranexus.com. Theranexus has developed a versatile proprietary technology leading to first in class products to address severe unmet medical needs in brain disorders.
|
|
TiGenixtigenix.com. TiGenix NV is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic, or donor-derived, expanded stem cells.
|
TxCelltxcell.com. TxCell is a biotech company developing innovative celltherapy platforms based on regularoty T cells (Tregs) to treat severe autoimmune and inflammatory disorders.
|
VitaDXvitadx.com. VitaDX develops a non-invasive solution for early bladder cancer diagnosis.
|